If Prediction #1 marked AI’s move into the core of life sciences operations, Prediction #2 defines how that AI will operate: not as passive copilots, but as agentic systems that reason, plan, and execute work autonomously. In CapeStart & MadeAi’s 2026 Predictions for AI in Life Sciences webinar, Angeline Dhas, Head of Product Management for…
Every professional in the life sciences knows the feeling: literature review is challenging, time-consuming, and above all, exhausting. This essential step in research can feel like a massive hurdle, slowing down innovation and consuming countless hours.
Recognizing this frustration, MadeAi developed MadeAi-LR, a powerful GenAI-enabled solution designed to transform the literature review process. It provides the…
The promise of Artificial Intelligence (AI) in life sciences is undeniable—offering advancements in drug discovery, clinical research, and evidence generation. Yet, many organizations still struggle to implement AI effectively. To better understand these challenges, CapeStart conducted a survey of 104 life science professionals, asking them: What are the top three barriers to success for your…
